Ignite Creation Date:
2024-05-05 @ 11:07 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01267214
Status:
COMPLETED
Last Update Posted:
2012-11-21
First Post:
2010-12-23
Brief Title:
The Efficacy and Safety of Intraarticular Sodium Hyaluronate Hyalgan After Proximal Tibial Osteotomy in Treatment of Knee Osteoarthritis Patients
Sponsor:
TRB Chemedica
Organization:
TRB Chemedica
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy and safety of Hyalgan after proximal tibial osteotomy in treatment of knee osteoarthritis patients Normally OA patients who were treated with osteotomy will not be treated with any SYSADOA after operation even though their cartilages not completely loss so osteotomy plus HA injection should provide more benefit to patients than osteotomy alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None